IGC Pharma
IGC
#10712
Rank
C$33.68 M
Marketcap
C$0.29
Share price
2.20%
Change (1 day)
-45.91%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -C$9.05 Million

According to IGC Pharma's latest financial reports the company's current earnings are C$1.18 Million. In 2025 the company made an earning of -C$7.55 Million, an increase over its 2024 earnings that were of -C$12.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$9.05 Million19.86%
2025 -C$7.55 Million-39.35%
2024 -C$12.45 Million-37.72%
2023 -C$19.98 Million1.19%
2022 -C$19.75 Million21.96%
2021 -C$16.19 Million27.13%
2020 -C$12.74 Million57.16%
2019 -C$8.11 Million85.47%
2018 -C$4.37 Million52.76%
2017 -C$2.86 Million-16.23%
2016 -C$3.42 Million-28.75%
2015 -C$4.8 Million-19.59%
2014 -C$5.96 Million6.79%
2013 -C$5.59 Million-9.47%
2012 -C$6.17 Million-74.03%
2011 -C$23.74 Million119.78%
2010 -C$10.8 Million62.02%
2009 -C$6.67 Million74.39%
2008 -C$3.83 Million-313.12%
2007 C$1.79 M-35.94%
2006 C$2.79 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
C$1.10 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
C$1.03 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-C$93.91 Million 915.47%๐Ÿ‡บ๐Ÿ‡ธ USA